Mckesson Corp (MCK) 184.96 $MCK SmarTrend Watching for

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Mckesson Corp (MCK) 184.96 $MCK

SmarTrend Watching for Potential Rebound in Shares of McKesson After 1.70% Loss
Comtex SmarTrend(R) - Thu Aug 25, 12:08PM CDT
McKesson (NYSE:MCK) traded in a range yesterday that spanned from a low of $185.00 to a high of $187.90. Yesterday, the shares fell 1.7%, which took the trading range below the 3-day low of $188.64 on volume of 1.1 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
MCK: 184.96 (+0.27)

McKesson Set to Possibly Rebound After Yesterday's Selloff of 1.70%
Comtex SmarTrend(R) - Thu Aug 25, 12:07PM CDT
McKesson (NYSE:MCK) traded in a range yesterday that spanned from a low of $185.00 to a high of $187.90. Yesterday, the shares fell 1.7%, which took the trading range below the 3-day low of $188.64 on volume of 1.1 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
MCK: 184.96 (+0.27)

McKesson (MCK) Approaches New Downside Target of $185.46
Comtex SmarTrend(R) - Thu Aug 25, 8:36AM CDT
McKesson (NYSE:MCK) has opened bearishly below the pivot of $190.40 today and has reached the first level of support at $187.23. Should the shares continue to fall, the support pivots of $185.46 and $180.52 will be of interest.
MCK: 184.96 (+0.27)

McKesson Corporation To Present at the Morgan Stanley Global Healthcare Conference
BusinessWire - Tue Aug 23, 3:10PM CDT
McKesson Corporation (NYSE:MCK) today announced that James Beer, the company's executive vice president and chief financial officer, will present at the Morgan Stanley Global Healthcare Conference in New York at 10:00 a.m. ET on Tuesday, September 13, 2016. Audio webcasts will be available live and archived on the company's Investor Relations website at http://investor.mckesson.com. A complete listing of upcoming events for the investment community is available on the company's Investor Relations website.
MCK: 184.96 (+0.27), MS: 31.69 (-0.06)

Top Research Reports for Morgan Stanely, Union Pacific & AbbVie
Sheraz Mian - Zacks Investment Research - Mon Aug 01, 2:21PM CDT
Top Research Reports for Morgan Stanely, Union Pacific & AbbVie
KO: 43.64 (-0.15), MCK: 184.96 (+0.27), NWL: 53.63 (-0.41), ABBV: 64.97 (+0.36), APD: 157.40 (unch), UNP: 96.28 (+0.31), MS: 31.69 (-0.06)

McKesson (MCK) Beats on Q1 Earnings, Maintains Guidance
Zacks Equity Research - Zacks Investment Research - Thu Jul 28, 9:11AM CDT
McKesson Corporation (MCK) reported first-quarter fiscal 2017 (ended Jun 30, 2016) earnings of $3.50 per share, above the Zacks Consensus Estimate of $3.35.
ABC: 87.75 (+0.12), JNJ: 119.61 (-0.14), MCK: 184.96 (+0.27), BMY: 56.57 (-0.39)

McKesson Reports Fiscal 2017 First-Quarter Results
BusinessWire - Wed Jul 27, 3:10PM CDT
--First-quarter GAAP earnings per diluted share from continuing operations of $2.88, up 15% year-over-year.
MCK: 184.96 (+0.27)

Air Methods Announces New Chief Financial Officer
GlobeNewswire - Wed Jun 01, 3:01PM CDT
Air Methods Corporation (Nasdaq:AIRM) announced that Peter Csapo will join America's largest air medical provider and helicopter operator as chief financial officer (CFO). Csapo will begin his new role effective June 6, succeeding Trent Carman who will be stepping down from his role of more than 13 years.
AIRM: 35.75 (+0.20), MCK: 184.96 (+0.27)

McKesson Declares Quarterly Dividend May 25, 2016
BusinessWire - Wed May 25, 3:10PM CDT
The Board of Directors of McKesson Corporation (NYSE:MCK) today declared a regular dividend of twenty-eight cents per share on Common Stock. The dividend will be payable on July 1, 2016, to stockholders of record on June 6, 2016.
MCK: 184.96 (+0.27)

Joliet Radiological Service Corp. Chooses McKesson
BusinessWire - Tue May 24, 8:00AM CDT
Joliet Radiological Service Corp. has contracted with McKesson Business Performance Services (McKesson) for comprehensive revenue cycle management services. The practice, based in Joliet, Illinois, seeks improved collections and benchmarking, as well as a stronger working relationship with its revenue cycle partner.
MCK: 184.96 (+0.27)

Imperva Appoints Randall Spratt to its Board of Directors
GlobeNewswire - Mon May 23, 3:15PM CDT
Imperva, Inc. (NYSE:IMPV), committed to protecting business-critical data and applications in the cloud and on-premises, today announced that Randall Spratt has joined its Board of Directors. Spratt is a senior technology executive with deep experience in the healthcare information industry and a successful leadership track record spanning start-ups to world-class organizations, including McKesson Corporation, a multi-billion dollar healthcare giant.
MCK: 184.96 (+0.27), IMPV: 46.11 (+0.06)

Wal-Mart Ties up with McKesson to Boost Pharmacy Offerings
Zacks Equity Research - Zacks Investment Research - Wed May 18, 8:03AM CDT
Retail giant Wal-Mart Stores Inc. (WMT) has been looking to strengthen its health-related business as well as cut costs in its pharmacy operations.
AMZN: 784.48 (-4.39), MCK: 184.96 (+0.27), KR: 31.32 (-1.35), WMT: 72.06 (-0.94)

Apple, Anacor and Tribune Publishing climb, Trevena skids
AP - Mon May 16, 3:21PM CDT
NEW YORK (AP) — Stocks that moved substantially or traded heavily Monday:
TRVN: 6.80 (-0.05), TPUB: 13.96 (+0.17), MCK: 184.96 (+0.27), PFE: 34.84 (+0.07), MRD: 15.63 (+0.04), TEX: 25.04 (+0.50), ANAC: 99.06 (-0.14), MRO: 15.69 (+0.05), AAPL: 108.36 (+0.66)

Look for Shares of McKesson to Potentially Pullback after Yesterday's 4.03% Rise
Comtex SmarTrend(R) - Mon May 16, 12:45PM CDT
McKesson (NYSE:MCK) traded in a range yesterday that spanned from a low of $168.58 to a high of $173.49. Yesterday, the shares gained 4.0%, which took the trading range above the 3-day high of $171.97 on volume of 935,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
MCK: 184.96 (+0.27)

McKesson Rises 4.03% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Mon May 16, 12:43PM CDT
McKesson (NYSE:MCK) traded in a range yesterday that spanned from a low of $168.58 to a high of $173.49. Yesterday, the shares gained 4.0%, which took the trading range above the 3-day high of $171.97 on volume of 935,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
MCK: 184.96 (+0.27)

Dominion Pathology Associates Chooses McKesson
BusinessWire - Mon May 16, 8:00AM CDT
Dominion Pathology Associates, PC, based in Roanoke, Va., has chosen McKesson Business Performance Services (McKesson) to provide comprehensive revenue cycle management services. McKesson was selected on the strength of the company's expertise in pathology billing, commitment to customer service and ancillary support capabilities, including strategic planning and marketing.
MCK: 184.96 (+0.27)

McKesson and Walmart Announce Sourcing Agreement for Generic Pharmaceuticals
BusinessWire - Mon May 16, 7:00AM CDT
--Agreement leverages McKesson's demonstrated strength and expertise in the global pharmaceutical industry and Walmart's proven commitment to delivering leading health and wellness services at an everyday low price
MCK: 184.96 (+0.27), WMT: 72.06 (-0.94)

Independent Emergency Medicine Group Selects McKesson
BusinessWire - Mon May 09, 8:00AM CDT
Ridgewood, N.J.-based Valley Emergency Room Associates (VERA) has chosen McKesson Business Performance Services (McKesson) for assistance in strengthening the group's cash flow, analytics reporting and regulatory compliance.
MCK: 184.96 (+0.27)

Downgrade Alert for McKesson (MCK)
Comtex SmarTrend(R) - Fri May 06, 3:33AM CDT
McKesson (NYSE:MCK) was downgraded from Outperform to Market Perform at Avondale today. The stock closed yesterday at $172.70 on volume of 3.9 million shares, above average daily volume of 1.4 million. There is potential upside of 31.8% for shares of McKesson based on a current price of $172.70 and an average consensus analyst price target of $227.64. The stock should find resistance at its 200-day moving average (MA) of $182.82, as well as support at its 50-day MA of $163.32.
MCK: 184.96 (+0.27)

Weight Watchers and Kraft climb, L Brands and Fitbit skid
AP - Thu May 05, 3:30PM CDT
NEW YORK (AP) — Stocks that moved substantially or traded heavily Thursday on the New York Stock Exchange and the Nasdaq stock market:
WFM: 29.08 (-1.62), FIT: 14.80 (-0.31), MCK: 184.96 (+0.27), LB: 73.91 (+0.58), WTW: 10.47 (+0.19)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Elite Robots Expands Global Reach with Mobile Manipulators

Updated Category News Views 105

Robots Hitting the Road? Picture this: robots that aren't just bolted to a factory floor but roam the production lines like tireless workers on wheels. That's what Elite Robots is betting on with their shiny new ELITEMISSION mobile manipulators. Not Just Any Old Robot These bad boys combine a robotic arm with an autonomous mobile platform. Think of an octopus getting off...

Continue Reading
Innovent's Big Leap: Targeting European Lung Cancer Market

Updated Category News Views 228

Innovent's Regulatory Milestone in Europe They say every underdog has its day, and for Innovent Biologics, that time just might be now. Receiving a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) is no small potatoes. Especially when we're talking lung cancer—a notorious heavyweight in the cancer world. The Finer Details of Zybrivo’s...

Continue Reading
Lululemon Faces Class Action over Alleged Missteps

Updated Category News Views 13

Trouble Brewing for Lululemon Y'ever get that gut feeling when something doesn't smell right? Well, Lululemon Athletica (NASDAQ: LULU) investors are probably feeling that now. A class action's kicking up dust over what some are saying was a downright bumpy ride. The brainiacs at Robbins LLP urge those who've lost bucks riding the LULU train to step forward ahead of the...

Continue Reading
Fapon's MEDICA 2026 Bid: Game-Changer or Same Old?

Updated Category News Views 147

Fapon's Ambitious Pitch at MEDICA: A Real Deal? MEDICA 2026 sees Fapon stepping up, laden with flashy promises and hardened expertise. Set up in Düsseldorf, these folks are pushing their Local Manufacturing Solutions harder than a door-to-door vacuum seller. The main pitch? Bolstering local IVD production with their comprehensive tech transfer services. How many outfits...

Continue Reading
Dr. Kumar Joins Florida Cancer Specialists Team

Updated Category News Views 29

Welcoming a New Oncology Specialist to Bradenton What does a small but mighty addition mean for cancer care in Bradenton, Florida? Well, it feels like a big win for the locals. Dr. Vinod Kumar is the latest name to join the ranks of the Florida Cancer Specialists & Research Institute (FCS) at the Bradenton Cancer Center. With years under his belt in medical oncology and...

Continue Reading
Tips for a Dementia-Friendly Thanksgiving Gathering

Updated Category News Views 28

Thanksgiving's supposed to bring families round the table, right? But toss a few knuckleheads together, add a pinch of dementia, and suddenly it's like throwing dice at a craps table. The American Speech-Language-Hearing Association (ASHA) reckons they've got tricks up their sleeve to keep the holiday from unraveling. The Thanksgiving Reality Check The hustle, bustle, and...

Continue Reading
ICEYE Launches Gen5 SAR Satellite for Unrivaled Clarity

Updated Category News Views 60

Well, if you've been sleeping under a rock and missed the news, ICEYE just dropped another bombshell in the satellite biz. Gen5 is the name of the game, and it's claiming the spotlight for its razor-sharp imaging prowess. Now, we're talking about a satellite that supposedly snaps pictures with a resolution as fine as 11 cm. That's like spotting a flea on a dog's back from...

Continue Reading
Carolina Pines Tackles Rural Healthcare Myths on TV

Updated Category News Views 47

Rural Healthcare Battles the Big City Myth Picture this: you're in a tiny town where everyone knows your dog's name, but some think you've got to head to the city for top-notch medical care. That's where Carolina Pines Regional Medical Center steps in. They’ve snagged a spot on 'All Access with Andy Garcia', shining a light on how investments in tech and talent keep...

Continue Reading
2GenPen's Patent Push: Transforming Credit Analysis

Updated Category News Views 7

Changing the Game in Credit Analysis When you hear about a company snagging a patent, it's usually a big whoop-de-do; but 2GenPen's latest achievement is making some serious waves. This isn't some 'pat-yourself-on-the-back' sort of news – it's got teeth in the world of finance. These folks just locked down their second U.S. patent, number 12,784,096, and it's all about...

Continue Reading
Flagship's £100M London Move to Ignite AI Ventures

Updated Category News Views 131

London Calling: Flagship's New Venture Flagship Pioneering, the brain behind bustling biotech ventures like Moderna, is planting its flag in London. They're launching Flagship Origination Lab, U.K., their first real gig outside good ol' Cambridge, Massachusetts. They're diving in headfirst, sprinkling a whopping £100 million to brew up AI-native platform companies. And...

Continue Reading

Top 5 Most Recently Viewed Articles

Empowering Innovation: Schneider Electric's Climate Tech Event

Updated Category News Views 170

Exploring the Excitement of the Climate Tech in the City Event The Climate Tech in the City event embodies the spirit of innovation, uniting key players in the climate technology sector. Leading organizations like Schneider Electric are at the forefront, showcasing groundbreaking advancements and sustainable practices. This year's gathering promises a vibrant day filled...

Continue Reading
Ouster Transforms Chattanooga into a Smart Traffic Hub

Updated Category News Views 404

Ouster's Groundbreaking Initiative in Smart Traffic Management In a significant development for urban traffic management, Ouster, Inc. (NASDAQ: OUST), recognized for its state-of-the-art lidar sensors, has launched a transformative project in Chattanooga. This venture stands out as the largest lidar-enabled traffic system in the United States, boasting a remarkable...

Continue Reading
Bicara Therapeutics Business Highlights and Q1 2025 Financial Review

Updated Category News Views 520

Bicara Therapeutics Announces Key Developments and Q1 2025 Financial Results Latest data from ongoing clinical trials to be showcased at upcoming conferences. Strong financial position enables sustained development through 2029. Bicara Therapeutics Inc. (Nasdaq: BCAX), a pioneering clinical-stage biopharmaceutical firm, focuses on delivering groundbreaking bifunctional...

Continue Reading
IO Biotech Gears Up for December Conferences: Insights and Highlights

Updated Category News Views 148

IO Biotech Prepares for Key Investor Conferences IO Biotech, a trailblazer in developing groundbreaking immune-modulatory cancer vaccines, is set to join two prominent investor events this December. The company, listed under NASDAQ: IOBT, is known for its innovative approach in the biopharmaceutical industry, particularly in creating off-the-shelf therapeutic cancer...

Continue Reading
Cardinal Energy Secures $40 Million Through Latest Debenture Offering

Updated Category News Views 267

Cardinal Energy Ltd. Announces a Major Offering Cardinal Energy Ltd. is excited to inform investors about its latest initiative aimed at raising funds through a significant offering. The company has entered into an agreement with a selected group of underwriters who will help facilitate the sale of $40 million in senior subordinated unsecured debentures. This strategic...

Continue Reading